|
|
|
Volumn 9, Issue 4, 1996, Pages 362-371
|
|
Current use of low molecular weight heparins
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ARDEPARIN;
CY 222;
DALTEPARIN;
DANAPAROID;
DERMATAN SULFATE;
DEXTRAN;
ENOXAPARIN;
GLYCOSAMINOGLYCAN;
HEPARIN;
HEPARIN DERIVATIVE;
HEPARINOID;
HIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
NADROPARIN;
TINZAPARIN;
WARFARIN;
ANTICOAGULANT THERAPY;
BLEEDING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEEP VEIN THROMBOSIS;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG MECHANISM;
HEPARINIZATION;
HIP SURGERY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTOPENIA;
THROMBOSIS;
VASCULAR SURGERY;
ANTICOAGULANTS;
HEPARIN;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
PLATELET AGGREGATION;
RANDOMIZED CONTROLLED TRIALS;
THROMBOCYTOPENIA;
THROMBOSIS;
VASCULAR SURGICAL PROCEDURES;
|
|
EID: 0029801789
PISSN: 08957967
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (0)
|
